Welcome Message
Dear Friends and Colleagues,
On the occasion of BIT's 4th Annual World Congress of Endobolism 2014 and BIT's 3rd Annual World Congress of Diabetes 2014, I would like, on behalf of the Organizing Committee, to extend my warm welcome to all distinguished guests from all over the world.
The conferences, being held from November 13-16, 2014 in Haikou, China, are aimed to be the Asia's largest meetings dedicated to endocrinology and metabolism and diabetes. We work closely with Information Research Center of International Talents to improve the quality and clinical impact of our meetings. Since WCE-2011 in Xiamen, WCE-2012 and WCD-2012 in Beijing, WCE-2013 and WCD-2013 in Xi'an, the events have been well recognized as the most important international conventions on endocrinology and metabolism and diabetes. It was in every way extremely successful in spite of the preceding worldwide clinical and health problems.
WCE-2014 and WCD-2014 continue to focus not only on the needs of its practitioners, but also on the needs of referring scientists and patients. To that end, we invite and select renowned scientists to use this platform to report their achievements and communicate with the other colleagues. Through the conferences, we have a strong commitment to advance the overall quality of endocrinology and metabolism and diabetes and achieve even greater penetration in the diagnostics and management of patients with suspected or proven disease.
In addition to the dynamic scientific program, you will benefit from the wonderful experience in Haikou, China. Known as the "Coconut City", Haikou, the capital of Hainan Province and China's second largest island, is one of the most delightful destinations in China. With the sea on three sides, Haikou enjoys a long coastline that features excellent bathing beaches and seaside resorts. We hope you will enjoy this tropical island entitled "the Oriental Hawaii".
Finally, may I wish all the friends have a pleasant and healthy stay in this attractive city and BIT's 4th Annual World Congress of Endobolism 2014 and BIT's 3rd Annual World Congress of Diabetes 2014 a complete success!
Hosting Organization
Information Research Center of International Talent, China State Administration of Foreign Experts Affairs, China
Operating Organizations
Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision, China
BIT Congress Inc., China
Executive Chair
Dr. Xiaodan Mei, President of BIT Congress Inc., China
Advisory Board Members
WCE-2014
Dr. AgnieszkaChwałczyńska, Head of Laboratory of Biomonitoring, University of Physical Education, Poland
Dr. Ashok Bhaseen, Vice President Marketing and Sales at Pediapharm, Canada
Dr. BurkhardPoeggeler, Senior Scientist, Georg August University Göttingen& the Goettingen Research Campus, Germany
Dr. CorinaGalesanu, Clinical Professor, University of Medicine & Pharmacy Iaşi, Romania
Dr. David Coman, Associate Professor, The Royal Childrens Hospital, Australia
Dr. Don S. Schalch, Emeritus Professor of Medicine, University of Wisconsin School of Medicine & Public Health, USA
Dr. Dongmei Wu, Associate Professor, Department of BIN Fusion Technology, Chonbuk National University, Republic of Korea
Dr. Gunnar Johansson, Professor of Health Sciences, Halmstad University, Sweden
Dr. Horst Robenek, Senior Professor, Medical Faculty, Westfälische-Wilhelms-University of Münster, Germany
Dr. John A. Farmer, Professor of Medicine, Baylor College of Medicine Houston Texas, USA
Dr. Marc Hamilton, Professor, Pennington Biomedical Research Center, USA
Dr. Margit Mahlapuu, Associate Professor, University of Gothenburg, Sweden
Dr. Mohamed Shakir MD, Professor, Department of Endocrinology, Walter Reed National Military Medical Center, USA
Dr. Philip D. Chilibeck, Professor, College of Kinesiology, University of Saskatchewan, Canada
Dr. Pradip K. Sarkar, Professor in Biochemistry & Physiology, Department of Basic Sciences, Parker University, USA
Dr. Shi Fang Yan, Associate Professor, NYU School of Medicine, USA
Dr. SushelaChaidarun MD, Assistant Professor & Director of In-patient Diabetes Management, Dartmouth-Hitchcock Medical Center, USA
WCD-2014
Dr. Bing-Mei Zhu, Professor, Nanjing University of Chinese Medicine, China
Dr. Christopher Nolan, Professor, ACT Diabetes Services, Australia
Dr. Elena Smirnova, Head of the Chair of Endocrinology and Clinical Pharmacology, Perm State Medical Academy, Russia
Dr. Francois Prince, Professor, University of Montreal, Canada
Dr. Ian Martins, Principal Research Fellow, Edith Cowan University, Australia
Dr. IV Misnikova, Director, Moscow Regional Reserch Clinical Institute named after M.F.Vladimerski, Russia
Dr. Jae Bum Kim, Professor, Seoul National University, Republic of Korea
Dr. James E. Aikens, Associate Professor of Family Medicine, University of Michigan, USA
Dr. Jay Johnson, Director of Biosensor Technologies, YSI-Xylem, Yellow Springs, USA
Dr. Jin-Xiong She, Director, Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Georgia Regents University, USA
Joan HuaqiongShen, Chief Medical Officer, Jiangsu Hengrui Medicine LTD, China
Dr. Joe Colombo, Research Director, Drexel University College of Medicine; Medical Director & Executive VP, ANSAR Medical Technologies, Inc., USA
Dr. LeventSandalci, Clinical Operations Manager, Novo Nordisk Business Area Near East, Turkey
Dr. Robert M. Badeau, Junior Investigator in Molecular Medicine, Turku Positron Emission Tomography Centre, Finland
Dr. RonghuaZhuGe, Associate Professor, University of Massachusetts Medical School, USA
Dr. Satoru Mimura, CEO, Mimura & May Co., Ltd., Japan
Dr. ShaodongGuo, Assistant Professor, College of Medicine, Texas A&M University Health Science Center, USA
Dr. Thomas Hach, Senior Medical Director, BoehringerIngelheim, Germany
Dr. Victor Lee Tswen Wen, Senior Consultant Surgeon, Singapore General Hospital, Adjunct Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Local Committee Members
Ms. Berry Han
Ms. Alice Gao
Mr. Dana Sun
Mr. Monica Huang
Mr. Teddy Wang
Sponsorship provides a great means of broadening your competitive edge by improving your company's image, prestige and credibility by supporting events that your target market finds attractive.
Sponsorship of events in particular can be especially effective as a marketing tool because it can be a means of accessing a wide range of audiences such as decision makers in business, government entities, and of course customers. It can be particularly beneficial for companies that take part in international trade, because sponsorship transcends cultural and language barriers.
In addition, sponsoring an event is actually just advertising your company to the masses, who will support your products and services. Organizers always acknowledge the sponsors of an event by putting their names in the poster, which people can see. Sponsoring an event can be beneficial to new enterprises for its exposure.
This conference offers a wide range of sponsoring categories for branding and highlighting your company in order to achieve the best publicity.
Want to know what types of sponsorship we provide to you?Or still have any questions about sponsoring at this conference, please do not hesitate to contact:
Ms. Fay Ren
BIT Congress Inc.
East Wing, 11F, Dalian Ascendas IT Park,
No. 1 Hui Xian Yuan,
Dalian Hi-tech Industrial Zone,
LN 116025, P.R.China
Tel& Fax: 0086-411-84799609 ext.827
Email: fay@bitlifesciences.com
Pharma Sources Insight July 2025
